Hello Patient

Name: Hello Patient
Brand: Hello Patient

AI Native

AI that handles patient communication perfectly, so healthcare teams can prioritize care.

Est 2024|Valuation $97M|Raised $28.8M|4 Ref Customers

LinkedIn 7K|Web traffic 2K|FTEs 45|HQ Austin, Texas, US

MarketsInteractive Voice Response (IVR)

Published Oct 10, 2026

01Common complaints

Company sizes or stages where this product is overkill or insufficient
- Solo or very small practices that mainly need two-way texting and reminders may find a simpler tool (e.g., OhMD Communicate tier) more cost-effective.
- Very large health systems with complex contact-center governance may prefer enterprise platforms oriented to that scope (e.g., Assort Health).
Industries or use cases where competitors are clearly superior
- Dental practices wanting fully integrated VoIP + communications suite with broad community references may prefer Weave.
- Practices wanting a broader “practice operating system” including EHR/billing/marketing may choose Tebra (though it carries suite complexity).
Technical requirements that this product cannot meet
- If a buyer requires published ISO 27001 certification or detailed public security documentation, Hello Patient’s public materials (in the sources found) may be insufficient.
- If a buyer requires languages beyond English/Spanish as a must-have (vendor indicates English/Spanish and “more upon request”), confirm roadmap and current production support.
Budget constraints that make alternatives more appropriate
- If priced at enterprise voice-agent levels, it may be uneconomical for low-volume clinics.
Specific workflows or integrations where the product falls short
- High-risk workflows like medication refills and complex clinical triage may require strict controls and may still need human oversight; buyers should validate guardrails and escalation behavior.
Red flags in the buying process (e.g., requires annual commitment, no free trial)
- Pricing is sales-led; buyers should clarify contract length, termination terms, and whether the “3-month risk-free pilot” is truly no-penalty.
Current limitations acknowledged by the vendor
- Not explicitly listed as “limitations,” but vendor indicates:
  - Additional languages beyond English/Spanish are “upon request,” suggesting not all languages are turnkey.
  - For systems without API access, CSV/custom solutions may be used—implying limitations in “seamless integration” for some stacks.
Features on the roadmap (not yet available) - note estimated dates if available
- No public roadmap dates found in accessible sources.
Scale limitations (at what volume/size does it break down?)
- No public performance benchmarks (latency, concurrency, max call volume) found.
Security or compliance gaps
- SOC 2 is claimed, but detailed enterprise security controls and ISO certifications are not publicly documented in sources captured.
Technical debt or architectural limitations mentioned in reviews
- No independent reviews available to substantiate.
API limitations or integration constraints
- Reliance on HL7/FHIR availability; otherwise CSV/custom integration paths.

- Company sizes or stages where this product is overkill or insufficient - Solo or very small practices that mainly need two-way texting and reminders may find a simpler tool (e.g., OhMD Communicate tier) more cost-effective. - Very large health systems with complex contact-center governance may prefer enterprise platforms oriented to that scope (e.g., Assort Health). - Industries or use cases where competitors are clearly superior - Dental practices wanting fully integrated VoIP + communications suite with broad community references may prefer Weave. - Practices wanting a broader “practice operating system” including EHR/billing/marketing may choose Tebra (though it carries suite complexity). - Technical requirements that this product cannot meet - If a buyer requires published ISO 27001 certification or detailed public security documentation, Hello Patient’s public materials (in the sources found) may be insufficient. - If a buyer requires languages beyond English/Spanish as a must-have (vendor indicates English/Spanish and “more upon request”), confirm roadmap and current production support. - Budget constraints that make alternatives more appropriate - If priced at enterprise voice-agent levels, it may be uneconomical for low-volume clinics. - Specific workflows or integrations where the product falls short - High-risk workflows like medication refills and complex clinical triage may require strict controls and may still need human oversight; buyers should validate guardrails and escalation behavior. - Red flags in the buying process (e.g., requires annual commitment, no free trial) - Pricing is sales-led; buyers should clarify contract length, termination terms, and whether the “3-month risk-free pilot” is truly no-penalty. - Current limitations acknowledged by the vendor - Not explicitly listed as “limitations,” but vendor indicates: - Additional languages beyond English/Spanish are “upon request,” suggesting not all languages are turnkey. - For systems without API access, CSV/custom solutions may be used—implying limitations in “seamless integration” for some stacks. - Features on the roadmap (not yet available) - note estimated dates if available - No public roadmap dates found in accessible sources. - Scale limitations (at what volume/size does it break down?) - No public performance benchmarks (latency, concurrency, max call volume) found. - Security or compliance gaps - SOC 2 is claimed, but detailed enterprise security controls and ISO certifications are not publicly documented in sources captured. - Technical debt or architectural limitations mentioned in reviews - No independent reviews available to substantiate. - API limitations or integration constraints - Reliance on HL7/FHIR availability; otherwise CSV/custom integration paths.

Why some customers left for competitors (churn reasons)

No direct churn narratives were found in accessible sources for Hello Patient.
In adjacent categories, common churn drivers for patient engagement/communication tools include price increases, support issues, and poor integration; attributing these specifically to Hello Patient would be speculative.

02Why they buy

Competitive advantages validated by customer feedback (not just vendor claims)
- Limited independent reviews; strongest available “customer feedback” is vendor-published testimonials and light practitioner mentions.
- Practitioner discussion supports that Hello Patient is perceived as a strong option, but also stresses integration as the deciding factor.
Unique features and capabilities competitors lack
- Claimed multi-agent / verticalized healthcare approach is emphasized in some coverage, but not independently benchmarked against competitors in accessible sources.
Differentiation from competitors based on reviews
- Not enough third-party reviews to reliably attribute differentiation.
Value propositions with evidence from case studies
- Vendor case study presence (Octave) and press references provide some credibility, but metrics and methodology are limited in public snippets.
Areas where competitors clearly have advantages (be balanced)
- OhMD: transparent starting prices and tier packaging.
- Weave: established market presence and integrated telephony suite; more third-party discussion in dental communities.
- Assort Health: clearer enterprise-oriented pricing ranges and likely stronger fit for large health system call centers.

- Competitive advantages validated by customer feedback (not just vendor claims) - Limited independent reviews; strongest available “customer feedback” is vendor-published testimonials and light practitioner mentions. - Practitioner discussion supports that Hello Patient is perceived as a strong option, but also stresses integration as the deciding factor. - Unique features and capabilities competitors lack - Claimed multi-agent / verticalized healthcare approach is emphasized in some coverage, but not independently benchmarked against competitors in accessible sources. - Differentiation from competitors based on reviews - Not enough third-party reviews to reliably attribute differentiation. - Value propositions with evidence from case studies - Vendor case study presence (Octave) and press references provide some credibility, but metrics and methodology are limited in public snippets. - Areas where competitors clearly have advantages (be balanced) - OhMD: transparent starting prices and tier packaging. - Weave: established market presence and integrated telephony suite; more third-party discussion in dental communities. - Assort Health: clearer enterprise-oriented pricing ranges and likely stronger fit for large health system call centers.

Why customers chose this product over alternatives

Vendor and press framing suggests customers choose Hello Patient for:
- Fully conversational scheduling vs phone trees
- 24/7 responsiveness
- Integration with EHR/PMS/CRM
- A “done-for-you” deployment approach with tuning
Press coverage indicates clients include several named clinics and med spas.

03Field reports

Direct quotes from Gartner Peer Insights, Reddit, TrustRadius, G2, HackerNews

Gartner Peer Insights
- Attempted but inaccessible for Hello Patient-specific reviews: public Gartner Peer Insights landing pages were accessible, but no Hello Patient product review page was found in accessible results.
G2
- Hello Patient’s G2 seller page indicates not enough reviews to provide buying insight.
TrustRadius
- No clear TrustRadius product page with Hello Patient reviews was found in accessible results (search surfaced unrelated PDFs and pricing pages for other vendors).
Reddit (healthcare practitioner community)
- Positive-leaning mention (comparison shopping / options):
  - “Hello patient seems to have a very good one.” (thread discussing voice AI options; emphasis on integration depth as the key differentiator).
- Neutral/early-stage trial intent:
  - “I’m trying out hello patient next week.” (thread asking about AI answering services).
HackerNews
- Attempted search for Hello Patient on news.ycombinator.com; no clearly relevant discussion thread was surfaced in accessible results.

- Gartner Peer Insights - Attempted but inaccessible for Hello Patient-specific reviews: public Gartner Peer Insights landing pages were accessible, but no Hello Patient product review page was found in accessible results. - G2 - Hello Patient’s G2 seller page indicates not enough reviews to provide buying insight. - TrustRadius - No clear TrustRadius product page with Hello Patient reviews was found in accessible results (search surfaced unrelated PDFs and pricing pages for other vendors). - Reddit (healthcare practitioner community) - Positive-leaning mention (comparison shopping / options): - “Hello patient seems to have a very good one.” (thread discussing voice AI options; emphasis on integration depth as the key differentiator). - Neutral/early-stage trial intent: - “I’m trying out hello patient next week.” (thread asking about AI answering services). - HackerNews - Attempted search for Hello Patient on news.ycombinator.com; no clearly relevant discussion thread was surfaced in accessible results.

BALANCE: Include both 5-star AND 1-2 star reviews with equal weight

Constraint: major review platforms do not currently show a meaningful volume of Hello Patient end-user reviews in accessible sources.
As a result, there is insufficient evidence to present a true “5-star vs 1-star” distribution for Hello Patient specifically.
The only accessible user-sourced quotes found were a small number of Reddit mentions and vendor-published testimonials.

Common criticisms and complaints (support issues, bugs, missing features)

From the limited Reddit practitioner discussion, the most prominent concern is whether the system can integrate deeply enough to complete real workflows (e.g., refills, scheduling, routing) rather than just answering FAQs.
Lack of transparent pricing and limited third-party reviews are practical buyer concerns (hard to validate ROI and reliability externally).

Specific outcomes customers achieved (with metrics when available)

Vendor claims on the main website include:
- Claims of full answer coverage across calls, texts, and chat
- Claims of a double-digit increase in appointments booked
- Claims of a very large reduction in patient wait times
Specialty page examples claim very fast answer times and double-digit increases in scheduled appointments, alongside a vendor-calculated ROI model for dental.
These are vendor-published figures and methodology details are limited; they should be treated as directional rather than independently verified.

- Vendor claims on the main website include: - Claims of full answer coverage across calls, texts, and chat - Claims of a double-digit increase in appointments booked - Claims of a very large reduction in patient wait times - Specialty page examples claim very fast answer times and double-digit increases in scheduled appointments, alongside a vendor-calculated ROI model for dental. - These are vendor-published figures and methodology details are limited; they should be treated as directional rather than independently verified.

Customer pain points and frustrations mentioned in reviews

Practitioner discussion emphasizes the risk that voice AI fails if it can’t actually execute integrated tasks (not just converse), particularly around medication refills and workflow routing.

Deal-breakers and reasons customers didn't purchase

Not directly documented for Hello Patient; likely deal-breakers to validate include:
- Inability to integrate with the buyer’s EHR/PMS
- Lack of required languages beyond English/Spanish
- Insufficient security documentation for enterprise review
- Concerns about AI safety/accuracy in clinical-adjacent conversations

Case Studies

Detailed customer success stories with metrics
- Vendor case studies page highlights Octave Therapy.
- Octave case study quote (vendor-published): “Only early into our partnership with Hello Patient, I can confidently report that our expectations have not only been met, but exceeded.” (Raul Estrada, VP of Operations, Octave).
Specific results and quantified business impact
- The accessible snippet of the case study page does not provide hard metrics; additional metrics may exist inside the full case study page, but were not captured in the snippet results.
- Vendor site broadly claims operational improvements (appointment volume, wait time reduction), but these are not tied to a fully described baseline, sample size, or independent verification.
Implementation details and time to value
- Vendor marketing suggests a brief multi-step onboarding (workflow discovery, tailoring the assistant, then go live).
- The Octave quote references a multi-month partnership horizon.
Challenges faced during adoption and how they were resolved
- Not described in accessible snippets; this is a common weakness in vendor-authored case studies.
CRITICAL: Note when metrics are vendor-published without independent verification
- All ROI models and performance claims found are vendor-published or vendor-amplified, including content shared via investor/partner channels, without independent audit.
Note methodology gaps (e.g., "ROI calculated by vendor, methodology not disclosed")
- The dental specialty page includes an ROI calculator presented as a “here’s the math” tool with assumptions based on vendor customer data, but without a disclosed dataset, confidence intervals, or an externally validated methodology.
Include mixed results - projects that struggled or failed when available
- No documented failed or struggling adoption stories were found in accessible sources.

- Detailed customer success stories with metrics - Vendor case studies page highlights Octave Therapy. - Octave case study quote (vendor-published): “Only early into our partnership with Hello Patient, I can confidently report that our expectations have not only been met, but exceeded.” (Raul Estrada, VP of Operations, Octave). - Specific results and quantified business impact - The accessible snippet of the case study page does not provide hard metrics; additional metrics may exist inside the full case study page, but were not captured in the snippet results. - Vendor site broadly claims operational improvements (appointment volume, wait time reduction), but these are not tied to a fully described baseline, sample size, or independent verification. - Implementation details and time to value - Vendor marketing suggests a brief multi-step onboarding (workflow discovery, tailoring the assistant, then go live). - The Octave quote references a multi-month partnership horizon. - Challenges faced during adoption and how they were resolved - Not described in accessible snippets; this is a common weakness in vendor-authored case studies. - CRITICAL: Note when metrics are vendor-published without independent verification - All ROI models and performance claims found are vendor-published or vendor-amplified, including content shared via investor/partner channels, without independent audit. - Note methodology gaps (e.g., "ROI calculated by vendor, methodology not disclosed") - The dental specialty page includes an ROI calculator presented as a “here’s the math” tool with assumptions based on vendor customer data, but without a disclosed dataset, confidence intervals, or an externally validated methodology. - Include mixed results - projects that struggled or failed when available - No documented failed or struggling adoption stories were found in accessible sources.

04Best fit

Ideal Customer Profile

Company sizes: specific employee counts and revenue ranges
- Best-fit indicators suggest:
  - Multi-location practices (multiple clinic sites)
  - Front-desk / call-center–heavy operations
  - Mid-size to large provider groups, though smaller single-location practices could adopt if call volume is high
- Revenue ranges will vary by specialty; the common thread is high inbound/outbound communication volume
Industries and verticals where adoption is strongest (with customer examples)
- Urgent care, dental, dermatology, orthopedics, ENT, med spas, mental health, veterinary
- Press cites clients including Revive Med Spa and Octave
Roles and personas: decision makers AND end users
- Decision makers
  - VP, Practice Operations
  - COO for multi-site groups
  - Patient Access / Call Center leaders
  - CIO/CTO for integration/security approval (especially health systems)
- End users
  - Front desk staff
  - Scheduling teams
  - Patient access representatives
  - Clinic managers
Pain points and challenges the product addresses
- Missed calls and long hold times
- Staff burnout from repetitive scheduling and questions
- Leakage of high-intent appointment demand after-hours
- No-show recovery and lapsed patient recall at scale
Qualification criteria: what makes a GREAT fit
- High call volume with a measurable missed-call rate
- Clear, standardized scheduling rules (or willingness to standardize)
- EHR/PMS with accessible APIs or willingness to invest in integration
- Strong operational ownership of patient access workflows
Deal disqualifiers: what makes a POOR fit
- Very low call volume (ROI unlikely)
- Highly bespoke scheduling complexity with frequent exceptions and minimal standardization
- Inability to sign a BAA or meet security requirements
- Organizations requiring extensive public documentation of security controls before vendor engagement
Real customer examples with company names when available
- Octave (Octave Health/Therapy referenced in press and vendor case studies)
- Revive Med Spa (press)

- Company sizes: specific employee counts and revenue ranges - Best-fit indicators suggest: - Multi-location practices (multiple clinic sites) - Front-desk / call-center–heavy operations - Mid-size to large provider groups, though smaller single-location practices could adopt if call volume is high - Revenue ranges will vary by specialty; the common thread is high inbound/outbound communication volume - Industries and verticals where adoption is strongest (with customer examples) - Urgent care, dental, dermatology, orthopedics, ENT, med spas, mental health, veterinary - Press cites clients including Revive Med Spa and Octave - Roles and personas: decision makers AND end users - Decision makers - VP, Practice Operations - COO for multi-site groups - Patient Access / Call Center leaders - CIO/CTO for integration/security approval (especially health systems) - End users - Front desk staff - Scheduling teams - Patient access representatives - Clinic managers - Pain points and challenges the product addresses - Missed calls and long hold times - Staff burnout from repetitive scheduling and questions - Leakage of high-intent appointment demand after-hours - No-show recovery and lapsed patient recall at scale - Qualification criteria: what makes a GREAT fit - High call volume with a measurable missed-call rate - Clear, standardized scheduling rules (or willingness to standardize) - EHR/PMS with accessible APIs or willingness to invest in integration - Strong operational ownership of patient access workflows - Deal disqualifiers: what makes a POOR fit - Very low call volume (ROI unlikely) - Highly bespoke scheduling complexity with frequent exceptions and minimal standardization - Inability to sign a BAA or meet security requirements - Organizations requiring extensive public documentation of security controls before vendor engagement - Real customer examples with company names when available - Octave (Octave Health/Therapy referenced in press and vendor case studies) - Revive Med Spa (press)

05The pitch

What the product does (core value proposition in objective terms)

Hello Patient is a healthcare-focused conversational AI platform (branded around an AI agent named “Mia”) that handles end-to-end patient communication across voice calls, SMS/text, and web chat.
The product is positioned as an “AI front desk / patient access layer” that answers inbound calls, schedules/reschedules appointments, routes/triages requests, runs outbound recall and no-show recovery, and supports adjacent workflows like intake and insurance verification (vendor and third-party descriptions).

- Hello Patient is a healthcare-focused conversational AI platform (branded around an AI agent named “Mia”) that handles end-to-end patient communication across voice calls, SMS/text, and web chat. - The product is positioned as an “AI front desk / patient access layer” that answers inbound calls, schedules/reschedules appointments, routes/triages requests, runs outbound recall and no-show recovery, and supports adjacent workflows like intake and insurance verification (vendor and third-party descriptions).

Target market and market positioning

Primary target appears to be high-volume outpatient and “retail-style” care settings (multi-location practices, PE-backed groups, and digital health providers) where front-desk / call-center capacity constraints lead to missed calls and poor patient access.
The vendor emphasizes “conversations, not phone trees” (anti-IVR positioning) and “no IT team required,” implying a managed/assisted deployment model rather than a self-serve developer toolkit.
Specialty marketing pages indicate focus across dentistry, dermatology, ENT, orthopedics, urgent care, mental health, optometry, med spas, primary care, and veterinary.

- Primary target appears to be high-volume outpatient and “retail-style” care settings (multi-location practices, PE-backed groups, and digital health providers) where front-desk / call-center capacity constraints lead to missed calls and poor patient access. - The vendor emphasizes “conversations, not phone trees” (anti-IVR positioning) and “no IT team required,” implying a managed/assisted deployment model rather than a self-serve developer toolkit. - Specialty marketing pages indicate focus across dentistry, dermatology, ENT, orthopedics, urgent care, mental health, optometry, med spas, primary care, and veterinary.

Get a comprehensive analysis of Hello Patient including market position, competitive landscape, adoption trends, and peer benchmarks.

Download full report →